Clinical trial
A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ…
NCT00090766 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00090766 |
|---|---|
| Title | A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients |
| Official title | Safety and Pharmacokinetics of Valganciclovir Syrup Formulation in Pediatric Solid Organ Transplant Recipients |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Cytomegalovirus Infections |
| Intervention type | Drug |
| Interventions | valganciclovir [Valcyte] |
| Enrollment | 63 |
| Start date | May 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Sep 6, 2004 |
| Last update posted | Oct 31, 2016 |
| Countries | Australia, Canada, France, Germany, Mexico, Spain, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: